Core Insights - Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on developing therapeutic proteins and antibodies targeting G-protein coupled receptors (GPCRs) [1][5] - The company will participate in three investor conferences in September 2025, providing opportunities for one-on-one meetings with management [1][4] Conference Details - **Wells Fargo Healthcare Conference** - Date: September 3, 2025 - Location: Boston, MA - Format: Investor Meetings [2] - **Cantor Global Healthcare Conference** - Date: September 4, 2025 - Time: 2:10 PM EDT - Location: New York, NY - Format: Fireside Chat - Presenters: Daniel Lochner (CFO) and Marc Schwabish, PhD (CBO) [2][3] - **Morgan Stanley 23 Annual Global Healthcare Conference** - Date: September 10, 2025 - Time: 3:20 PM EDT - Location: New York, NY - Format: Fireside Chat - Presenter: Alise Reicin, MD (President and CEO) [3] Company Overview - Tectonic utilizes its proprietary GEODe™ technology platform to enhance GPCR-targeted drug discovery, aiming to address significant unmet medical needs [5] - The company is headquartered in Watertown, Massachusetts, and focuses on developing biologic medicines to improve patient quality of life [5]